Next-Generation Sequencing (NGS) and Arrays to Profile Transcriptomic and Epigenomic Regulation in Cell Biology
Fraz Syed, PhD, Marketing Manager
Britt Flaherty, PhD, Product Manager
Kevin Taylor, PhD, Sr. Manager, Market Development, Complex Disease
Next-Generation Sequencing (NGS) and array platforms allow great flexibility when investigating various factors that can affect disease phenotype. Researchers can study gene mutations, gene expression and epigenetic regulation, while looking for molecular pathways that determine complex traits or diseases. Join us for a webinar that will focus on techniques used to profile the transcriptome and epigenome in complex disease.
Topics will include:
• Navigating the NGS workflow.
• Introduction to RNA-Seq and experimental design considerations.
• Methylation (bisulfite) sequencing and array basics and experimental design considerations.
• Highlights of recent publications that used these techniques to study complex disease.
For Research Use Only. Not for use in diagnostic procedures.